Table 2.
STI before and after EDM prescription among MSM in HIV Care
| Before EDM Prescription | ||||
|---|---|---|---|---|
| Positive N (%) |
Negative N (%) |
Total N (%) |
ORa (95% CI), p-value |
|
| After EDM | ||||
| Prescription | ||||
| Chlamydia | ||||
| Positive | 0 (0) | 2 (2.5) | 2 (2.5) | 0.25 (0.05–1.18) |
| Negative | 8 (9.9) | 71 (87.7) | 79 (97.5) | p= 0.08 |
| Total | 8 (9.9) | 73 (90.1) | 81 (100) | |
| Gonorrhea | ||||
| Positive | 1 (1.3) | 6 (7.5) | 7 (8.8) | 6.00 (0.72–49.84) |
| Negative | 1 (1.3) | 72 (90.0) | 73 (91.2) | p= 0.10 |
| Total | 2 (2.5) | 78 (97.5) | 80 (100) | |
| Syphilis | ||||
| Positive | 2 (0.8) | 14 (5.8) | 16 (6.6) | 1.27 (0.58–2.80) |
| Negative | 11 (4.6) | 214 (88.8) | 225 (93.4) | p= 0.55 |
| Total | 13 (5.4) | 228 (94.6) | 241 (100) | |
CI=confidence interval, EDM=erectile dysfunction/medication, OR=odds ratio; STI=sexually transmitted infection Bolded data highlights STIs detected before and after EDM.
a
Paired data analysis using conditional logistic regression used to calculate ORs with corresponding 95% CIs and p-values.